The Enso Study for Chronic Low Back Pain

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Chronic Low Back Pain

In brief

Enso is a portable device for the treatment of chronic and acute types of musculoskeletal pain. This study is being designed as a double-blinded, sham-controlled randomized clinical trial.

Key facts

Study ID

NCT03320863

Run by

Thimble Bioelectronics, Inc.

People needed

50

Starts

2017-11-09

Expected to finish

2021-01-30

Last updated by the study team

2020-01-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Mechanical (myofascial), axial back pain (focused around the spine)
• 6/10 or greater level of pain
• Functionally debilitated by their pain (e.g., difficulty walking)
• Minimal radicular symptoms with no effect on functionality, medication, quality of life
• Expressed desire to stop taking pain medications
• Expressed desire to improve disability
• 80% or greater of disability is due to pain in the low back (as opposed to other body areas)
• Experiencing chronic pain for at least 6 months
• Interested in being active, improving their functionality
• Comfortable with using technology in daily life
• Subject able to understand and grant informed consent
• Documented adherence with clinic follow up visits per medical records
• Has an email account
• Above 18 years old

You may not qualify if…

• Patients that do not own or have access to a smartphone
• Has spinal instability, joint instability, or grade 2 or greater spondylolisthesis with instability
• Primary symptoms due to spinal stenosis
• Source of back pain related to an acute nerve impingement
• Diagnosis of cancer/malignant tumors in the last 5 years
• Source of back pain is an infection
• Source of pain is a prior spinal fusion surgery
• Has a cardiac pacemaker, implanted defibrillator or other implanted electronic device
• Has radicular pain symptoms that affect functionality, quality of life or medication intake
• Has undergone surgery to solve pain related to the study indication in the past 6 months
• Patients with history of opioid, alcohol or drug abuse in the last 5 years, per investigator discretion
• Any psychiatric condition that may interfere with the study assessments or prevent the subject from complying with the requirements of the protocol, in the judgement of the investigator
• Inability to complete subjective data as required; e.g. on mobile application and questionnaires
• Pregnant women (as determined by self-report)
• Have severe epilepsy
• Have severe form of cardiovascular disease
• Any other disease, condition, or habit(s) that in the opinion of the Principal Investigator would interfere with study compliance or adversely affect study outcomes

Where it is running

• University of California Medical Center — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.